(PharmaNewsWire.Com, March 22, 2018 ) Scleroderma is an autoimmune disorder, which is a condition when body's tissues get attacked by the immune system. The term scleroderma is defined as the hardening of the skin; however, it is much more than the skin disorder. The disease is characterized by microvascular injury and fibrosis in the affected organs.
Publisher's analysts forecast the global scleroderma treatment market to grow at a CAGR of 7.02% during the period 2017-2021.
Covered in this report The report covers the present scenario and the growth prospects of the global scleroderma treatment market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Publisher's report, Global Scleroderma Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Other prominent vendors - Amgen - Bayer AG - Boehringer Ingelheim - Biogen - CELGENE - Corbus Pharmaceuticals - Johnson & Johnson - Merck - Novartis - Sanofi
Market driver - High unmet medical needs - For a full, detailed list, view our report
Market challenge - Unknown pathogenesis of the disorder - For a full, detailed list, view our report
Market trend - Partnerships and strategic alliances - For a full, detailed list, view our report
Table of Contents
PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE PART 05: MARKET SIZING PART 06: FIVE FORCES ANALYSIS PART 07: MARKET SEGMENTATION PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES PART 12: MARKET TRENDS PART 13: VENDOR LANDSCAPE PART 14: VENDOR ANALYSIS PART 15: APPENDIX
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
